Suchergebnisse - "Vallet, Sonia"

PubPharm (135)

31

CCR1 INHIBITORS USEFUL FOR THE TREAMENT OF MULTIPLE MYELOMA AND OTHER DISORDERS

enthalten in: Europäisches Patentamt | 2018

von VEIBY OLE PETTER | ANDERSON KENNTH C | VALLET SONIA

32

Adoptive cell therapy in multiple Myeloma

enthalten in: Expert opinion on biological therapy | 2017

von Vallet, S. | Pecherstorfer, M. | Podar, K.

33

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment

enthalten in: Leukemia | July 2017

von Fan, F. | Bashari, M. | Malvestiti, S. | +8

34

Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers

enthalten in: Journal of Cancer | 2017

von Zschäbitz, S. | Vallet, S. | Hadaschik, B. | +9

35

Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence

enthalten in: Urologic oncology | 2016

von Grüllich, C. | Vallet, S. | Hecht, C. | +5

36

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia : therapeutic implications

enthalten in: Breast cancer research : BCR | 2016

von Bashari, M. | Fan, F. | Vallet, S. | +11

ErratumIn: Breast Cancer Res. 2024 Apr 2;26(1):58. - PMID 38566222

37

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

enthalten in: Breast cancer research | 2016

von Bashari, M. | Fan, F. | Vallet, S. | +11

38

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

enthalten in: Breast cancer research | 2016

von Bashari, M. | Fan, F. | Vallet, S. | +11

39

Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway

enthalten in: PloS one | 2016

von Vallet, S. | Bashari, M. | Fan, F. | +5

40

Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence

enthalten in: Urologic oncology | 2016

von Grüllich, C. | Vallet, S. | Hecht, C. | +5